Supplemental material
Original Research
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia
Duc Q. Trana Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Emory University, Atlanta, Georgia, USACorrespondence[email protected]
https://orcid.org/0000-0002-6347-4452View further author information
https://orcid.org/0000-0002-6347-4452View further author information, , Judith A. Boicec Tremeau Pharmaceuticals, Concord, Massachusetts, USAhttps://orcid.org/0000-0001-5700-2742View further author information
https://orcid.org/0000-0001-5700-2742View further author information, Meera Chitlurd Division of Hematology/Oncology, Central Michigan University College of Medicine, Detroit, Michigan, USAhttps://orcid.org/0000-0001-7656-0694View further author information
https://orcid.org/0000-0001-7656-0694View further author information, Amy L. Dunne Division of Hematology, Oncology and Bone Marrow Transplant, Nationwide Children’s Hospital, Columbus, Ohio, USA;f Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USAhttps://orcid.org/0000-0002-9645-6365View further author information
https://orcid.org/0000-0002-9645-6365View further author information, Miguel A. Escobarg Division of Hematology, UTHealth Houston McGovern Medical School, Gulf States Hemophilia and Thrombophilia Center, Houston, Texas, USAhttps://orcid.org/0000-0002-2944-0240View further author information
https://orcid.org/0000-0002-2944-0240View further author information, Kalpna Guptah Center for Bleeding and Clotting Disorders, Division Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA;i Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, California, USAhttps://orcid.org/0000-0001-9381-9979View further author information
https://orcid.org/0000-0001-9381-9979View further author information, Jill M. Johnsenj Bloodworks Northwest, Seattle, Washington, USA;k Department of Medicine, University of Washington, Seattle, Washington, USA;l Washington Center for Bleeding Disorders, Seattle, Washington, USAhttps://orcid.org/0000-0002-2279-2550View further author information
https://orcid.org/0000-0002-2279-2550View further author information, , , , Shannon L. Meeksa Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Emory University, Atlanta, Georgia, USA;p Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta Inc, Atlanta, Georgia, USA and Department of Pediatrics, Emory University, Atlanta, Georgia, USAhttps://orcid.org/0000-0002-3683-8644View further author information
https://orcid.org/0000-0002-3683-8644View further author information, , Doris V. Quonr Orthopaedic Hemophilia Treatment Center, Orthopaedic Hospital of Los Angeles, California, USAhttps://orcid.org/0000-0002-9148-3268View further author information
https://orcid.org/0000-0002-9148-3268View further author information, , Ulrike M. Reisss Department of Hematology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USAhttps://orcid.org/0000-0002-2258-3687View further author information
https://orcid.org/0000-0002-2258-3687View further author information, , , Bruno Steinerl Washington Center for Bleeding Disorders, Seattle, Washington, USAhttps://orcid.org/0000-0001-9705-8900View further author information
https://orcid.org/0000-0001-9705-8900View further author information, , & Annette von Drygalskix Hemophilia & Thrombosis Treatment Center, University of California San Diego, California, USAhttps://orcid.org/0000-0002-9426-6322View further author information
https://orcid.org/0000-0002-9426-6322View further author information show all